Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 15 hours ago
microfluidic organs-on-chip and will involve working closely with postdoctoral fellows in the Lampe Joint Department of Biomedical Engineering and students and postdocs from the Eshleman School of Pharmacy
-
following: applied optics, photonic devices, microfluidics, sensor engineering, chemical sensing, or a closely related discipline. A2 A comprehensive and up-to-date knowledge of current issues and future
-
must possess detailed knowledge and experience in design and fabrication of microfluidic systems, with demonstratable skills in sensors, micro-fabrication, electronics and programming. We are looking
-
to identify novel drugs for repurposing as ALS therapeutics. We also generated a microfluidic device enabling the study of axonal RNP granules as well as the functionality of neuromuscular junctions. Here, we
-
instrument design/prototyping. Knowledge of microfluidic device design highly desirable. Knowledge of aerosol sampling, particle characterization, or biosensing methods advantageous. Excellent organizational
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 3 months ago
microfluidic devices, at all levels: design in CAD, SU8 to epoxy mold copy, PDMS preparation, PDMS casting; Experience with cellular/neuronal cultures on PDMS-based microfluidic devices; Proficiency, and full
-
will leverage a suite of high-throughput technologies developed in the Fordyce lab, including hydrogel beads and array-based microfluidic devices, to systematically measure parameters such as expression
-
or similar. Specific Requirements Experience in at least 1 of the following: molecular microbiology, microbiology of extremophiles, functional metagenomics, microfluidics, protein expression and purification
-
for live-cell imaging of RNP granules, facilitating compound screening to identify novel drugs for repurposing as ALS therapeutics. We also generated a microfluidic device enabling the study of axonal RNP
-
bacteria and represents a promising new target to prevent infections or biofouling. Using a patented Q reporter strain and developing multiplate and microfluidic workflows, Q inhibitors will be screened in